CYAD

Celyad Oncology SA American Depositary Shares
CYAD

Overview Fund Activity
Delisted

CYAD was delisted on the 18th of May, 2023.

Back to rankings

13 hedge funds and large institutions have $37.6M invested in Celyad Oncology SA American Depositary Shares in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RIM
RS Investment Management
California
+$12.4M
2
UBS Group
UBS Group
Switzerland
+$5.47M
3
Millennium Management
Millennium Management
New York
+$4.26M
4
PA
Perceptive Advisors
New York
+$3.9M
5
CAM
Cormorant Asset Management
Massachusetts
+$3.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
RIM
1
RS Investment Management
California
$12.4M +$12.4M +238,330 New
UBS Group
2
UBS Group
Switzerland
$5.47M +$5.47M +105,098 New
Millennium Management
3
Millennium Management
New York
$4.26M +$4.26M +81,942 New
PA
4
Perceptive Advisors
New York
$3.9M +$3.9M +75,000 New
CAM
5
Cormorant Asset Management
Massachusetts
$3.9M +$3.9M +75,000 New
HM
6
HealthCor Management
New York
$3.38M +$3.38M +65,000 New
FCM
7
Farallon Capital Management
California
$1.56M +$1.56M +30,000 New
DCM
8
DAFNA Capital Management
California
$1.56M +$1.56M +30,000 New
UOC
9
UBS O'Connor
Illinois
$780K +$780K +15,000 New
FMA
10
FNY Managed Accounts
New York
$286K +$286K +5,500 New
TRCT
11
Tower Research Capital (TRC)
New York
$41K +$41K +783 New
Morgan Stanley
12
Morgan Stanley
New York
$26K +$26K +500 New
AH
13
Achievement Holdings
Illinois
$1.09K +$1.09K +21,000 New